Feasibility of a High-intensity Interval Training Program in Persons With Multiple Sclerosis Who Have Walking Disability
A Single-group, Feasibility, and Initial Efficacy Study of a High-intensity Interval Training Program Using Adaptive Equipment in Persons With Multiple Sclerosis Who Have Walking Disability
1 other identifier
interventional
17
1 country
1
Brief Summary
There is considerable evidence to support the efficacy of moderate intensity continuous (MIC) exercise benefitting clinically-relevant outcomes in persons with multiple sclerosis (MS). However, persons with MS who have walking impairments (pwMS-wd) are severely deconditioned and may achieve superior benefits by engaging in high-intensity interval training (HIIT), especially while utilizing adaptive equipment, such as with recumbent arm/leg stepping (RSTEP). Of the published studies on HIIT in MS, HIIT yielded significant improvements in cardiorespiratory fitness in all but one study. In those studies that directly compared HIIT to MIC exercise, the data indicated a potential superiority of HIIT as compared to MIC in improving physiological conditioning in a time efficient manner. However, this evidence is specific to those with MS with mild to moderate disability engaging in cycle/arm ergometry and an investigation of HIIT in pwMS-wd is needed as the feasibility and potential benefits of engaging in HIIT in pwMS-wd is relatively unknown. The primary aim of the proposed study is to assess the feasibility of a 12-week, RSTEP HIIT program in pwMS-wd. The secondary aim is to examine changes in aerobic fitness, physical activity, ambulation, upper arm function, cognition, fatigue, and depressive symptoms as clinically-relevant efficacy outcomes following the 12-week, RSTEP HIIT intervention. It is hypothesized that the intervention will be feasible and lead to positive changes in aerobic fitness, physical activity, ambulation, upper arm function, cognition, fatigue, and depressive symptoms. This work is informed by recently published data, which indicate that a single bout of RSTEP HIIT taxes the cardiorespiratory system significantly more than MIC exercise, yet without untoward effects on walking, gait, cognition, mood, or enjoyment. These data suggest that RSTEP HIIT may be an acceptable, safe, and tolerable stimulus for chronic exercise training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Dec 2019
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 19, 2019
CompletedFirst Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2022
CompletedApril 19, 2023
April 1, 2023
3 years
May 28, 2020
April 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Recruitment, Retention, and Adherence Rates
Participant recruitment, retention, and adherence rates will be recorded.
From recruitment to end of treatment at 12 weeks.
Time Needs
Staff training, communication, recruitment, and intervention time will be recorded.
From recruitment to end of treatment at 12 weeks.
Monetary Needs
Monetary research costs will be recorded.
From recruitment to end of treatment at 12 weeks.
Data Management and Safety Reporting
Time from submission of Institutional Review Board application to approval will be recorded. All time spent collecting, entering, and checking data will be recorded.
From recruitment to end of treatment at 12 weeks.
Participant Burden Reporting
Participants' experience, burden, and perceptions will be assessed via a short survey at the end of the 12 weeks.
From recruitment to end of treatment at 12 weeks.
Safety Reporting
Adverse events, serious adverse events, and clinical emergencies will be recorded.
From recruitment to end of treatment at 12 weeks.
Secondary Outcomes (8)
Change in Aerobic Capacity
Week 0, Following Week 6, Following Week 12
Change in 6-Minute Walk Distance
Week 0, Following Week 6, Following Week 12
Change in 25-Foot Walk Speed
Week 0, Following Week 6, Following Week 12
Change in Sedentary, Light, and Moderate-to-Vigorous Counts of Physical Activity
Week 0, Following Week 6, Following Week 12
Change in the Brief International Cognitive Assessment in MS Scores
Week 0, Following Week 6, Following Week 12
- +3 more secondary outcomes
Study Arms (1)
Recumbent Stepping, High-Intensity Interval Training
EXPERIMENTALInterventions
The intervention will involve 12 weeks of supervised, progressive (i.e., intensity increases after midpoint testing based on reassessment of aerobic fitness) HIIT sessions two to three times per week. HIIT exercise sessions will be manualized and led by exercise leaders. Secondary outcomes testing will occur at baseline (week 0), midpoint (following week 6 of training), and post-intervention (following week 12 of training). The individual HIIT sessions will involve 10 cycles of 60s intervals at the wattage associated with 90% VO2peak followed by 60s of active recovery intervals at 15 watts, totaling 20 min in length. All exercise sessions will begin and end with a 5-minute warm-up and cool-down, respectively. Required power output for each interval of the exercise session will be individualized and completely automated. VO2peak from baseline and midpoint testing will be used to determine exercise intensity for weeks 1-6 and weeks 7-12, respectively.
Eligibility Criteria
You may qualify if:
- age 18 or over
- a self-reported diagnosis of multiple sclerosis
- self-reported Expanded Disability Status Scale (EDSS) score \< 8.0 or Patient Determined Disability Steps (PDDS) scale score ≤ 7.0
- relapse free in past 30 days
- willing and able to visit Berry College or University of North Texas on three testing occasions and twenty four training occasions
- asymptomatic status for maximal exercise testing; (g) physician approval for undertaking exercise testing
- a self-reported ability to speak, read, and understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Texas, Denton, TXlead
- University of Alabama at Birminghamcollaborator
- Berry Collegecollaborator
Study Sites (1)
University of North Texas
Denton, Texas, 76203, United States
Related Publications (1)
Hubbard EA, Motl RW, Elmer DJ. Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial. Trials. 2020 Nov 25;21(1):972. doi: 10.1186/s13063-020-04887-x.
PMID: 33239079DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie L Silveira, PhD
University of North Texas Health Science Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 4, 2020
Study Start
December 19, 2019
Primary Completion
December 14, 2022
Study Completion
December 14, 2022
Last Updated
April 19, 2023
Record last verified: 2023-04